BIOGEN (DENMARK) A/S: Financial statements 2015
CVR: 21682977
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
BIOGEN (DENMARK) A/S (CVR 21682977) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 298,427,977 and a net result of DKK 9,088,920 compared with DKK 8,064,013 the year before. That is an increase of 0.2% compared with the year before. The profit margin was 3%. Equity in the 2015 report amounted to DKK 57,456,988. The solvency ratio was 51.2%. The company had 29 employees in the financial year.
- Revenue
- DKK 298,427,977
- Gross Profit
- DKK 74,447,427
- Profit/Loss
- DKK 9,088,920
- Equity
- DKK 57,456,988
- Total Assets
- DKK 112,237,068
- Employees
- 29
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | 298.4 mio. | 74.4 mio. | 9.1 mio. | 57.5 mio. | 29 |
| 2014 | 297.9 mio. | 84.2 mio. | 8.1 mio. | 48.4 mio. | 26 |
| 2013 | 204.9 mio. | 64.9 mio. | 5.6 mio. | 40.3 mio. | 25 |
Official annual report
How creditworthy is BIOGEN (DENMARK) A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of July 1, 2015, Vesna Leskovsek Cizej has joined the board of directors of BIOGEN (DENMARK) A/S.
As of July 1, 2015, Thomas Lackner has left the board of directors of BIOGEN (DENMARK) A/S.
BIOGEN (DENMARK) A/S has published its annual report for 2014. Revenue came to DKK 297,858,497, and the net result was DKK 8,064,013.
As of April 1, 2015, Thomas Francois Etienne Biet has left the board of directors of BIOGEN (DENMARK) A/S.
As of March 31, 2015, Steven John Green has joined the board of directors of BIOGEN (DENMARK) A/S.
On March 23, 2015, the company changed its name from BIOGEN IDEC (DENMARK) A/S to BIOGEN (DENMARK) A/S.
About BIOGEN (DENMARK) A/S
BIOGEN (DENMARK) A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 1999. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named BIOGEN IDEC (DENMARK) A/S. The management consists of Erik Magnus Bodin. The board consists of Neil Raymond Sisak (chair), Allan Frank Fischer Petersen, Erik Magnus Bodin and Sergio Ferreira da Silva Teixeira. The company is owned by Biogen Netherlands B.V.. The company has 13 employees (2026). In 2025, the company reported revenue of DKK 178,728,185 and a net result of DKK 5,563,672 compared with DKK 7,526,703 the year before. Equity in the 2025 report amounted to DKK 151,886,117.